Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01165775 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 17
- Enrollment target
NCT01165775: Completed study, sponsored by Stanford University.
NCT01165775 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01165775 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent maternal and neonatal complications of hyperglycemia.
Primary Outcome
During a 24 hour monitoring period (24-48 hours post betamethasone treatment), which percentage of the time was spent above glucose thresholds (\>110;\>144;\>180)
Interventions
- DEVICE Dexcom Seven Plus Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-12 |
What the finished NCT01165775 record still lists
NCT01165775 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dexcom Seven Plus Continuous Glucose Monitoring System is the first listed.
NCT01165775 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01165775 about?
NCT01165775 is a clinical study titled "Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy". We hope to clarify how betamethasone affects glucose levels in the mother in the days after receiving the drug. This understanding will hopefully allow us to better anticipate the risk of maternal hyperglycemia and therefore establish more appropriate monitoring of maternal glucose to prevent matern...
What is the current status of trial NCT01165775?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2010-07. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01165775?
The interventions under investigation include: Dexcom Seven Plus Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT01165775?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia